Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
Analysis
Comment
Deals
Events
News
People

Flotation

Imara implements IPO
Pfizer and Lundbeck scored exits as blood-disease therapy developer Imara raised $75.2m, floating at the foot of its range.
Passage Bio amasses $248m for IPO close
The genetic therapy developer, which had raised $126m in funding from investors including Eli Lilly and Access Industries, added $32.4m to the offering.
Revolution hits public markets in $238m IPO
The precision cancer therapy developer, which counts Sanofi as a significant shareholder, floated at the top of an upsized range and saw its price continue to rise post-IPO.
Beam Therapeutics brings IPO to $207m close
The genomic drug developer, which counts GV as an investor, has completed its initial public offering, boosting its size from $180m to $207m.
Schrödinger shuts IPO at $232m
Drug and materials development software provider Schrödinger has capped a successful initial public offering at more than $232m.
Schrödinger shakes out $202m from IPO
The GV and Wuxi AppTec-backed drug development software producer floated above its range and saw its shares rise 68% on their first day of trading.
Beam Therapeutics shines in $180m IPO
Alphabet, Editas and Bio Palette-backed genomic medicine developer Beam will raise $180m in an upsized initial public offering three years after being spun out of Harvard University.
Casper catches $100m in initial public offering
The Target-backed mattress and bedding brand is floating at the bottom of its range, at a valuation of less than half that of its last funding round.

Other News

One Medical wanders onto public markets with $245m
The GV-backed primary care membership service floated at the bottom of its range but garnered a valution of more than $1.7bn.
UCloud stars in $284m IPO
Bertelsmann achieved an exit as the cloud services provider raised $284m in an initial public offering that reportedly valued it at about $2bn.
Danke Apartment deploys IPO
The Bertelsmann, UCommune and Ant Financial-backed property manager raised nearly $130m depite downsizing its initial public offering.
I-Mab enters public markets in $104m IPO
The Tasly and Genexine-backed drug developer floated above the mid-point of its range, in an initial public offering that could end up topping $119m.
Lizhi lists in $45m IPO
The Xiaomi-backed, China-headquartered podcast app developer priced its shares at the bottom of their range to raise $45.1m in a US offering.
OneConnect upgrades IPO to $347m
Ping An's financial technology spinoff, which also counts SoftBank Vision Fund and SBI as shareholders, has sold an additional $35.2m in shares in the offering.

Editor's Picks

Bill.com fills up with $216m IPO
Financial automation software producer Bill is floating above its range as Fleetcor, Mastercard, Amex and a host of banks all scored exits.
Peloton pulls itself to billion-dollar IPO
Comcast NBCUniversal and Grace Beauty scored exits as Peloton Interactive floated at the top of its range to raise $1.16bn, getting a further $100m in a private placement.
Cloudflare clocks up $525m in IPO
Alphabet, Baidu, Microsoft and Qualcomm all notched up exits as the cloud services provider floated above a range that had already been increased.
BridgeBio crosses over to public markets with $349m
AIG scored an exit as genetic disease and cancer drug developer BridgeBio Pharma floated above its range while increasing the number of shares in its IPO.
test reg

Login